Recurrent Childhood Acute Lymphoblastic Leukemia Completed Phase 1 Trials for Romidepsin (DB06176)

IndicationStatusPhase
DBCOND0028597 (Recurrent Childhood Acute Lymphoblastic Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00053963FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaTreatment